Colchicine for heart disease patients after stent placement
Treatments studied
Part of Heart & circulation clinical trials.
This study tests if colchicine, a medicine used for gout and inflammation, can help people with coronary heart disease who have had a stent placed. You might be eligible if you have ongoing inflammation (measured by a simple blood test) and are already on standard heart medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have symptoms or proof that your heart muscle is not getting enough blood (myocardial ischemia).
- You have had a successful stent procedure (PCI) to open a blocked artery.
- You have a blood test result showing a high sensitivity C-reactive protein (hs-CRP) level of 2 mg/L or higher (a sign of inflammation).
- You are taking the recommended standard medications for coronary heart disease.
- You do not have certain health issues like severe kidney or liver problems, a recent heart attack, or a history of intolerance to colchicine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether colchicine (a medicine used for gout) can help prevent heart problems after a stent procedure (PCI). It's for people who are in the hospital getting a stent and follow standard heart care.
This trial tests if colchicine, a common anti-inflammatory medicine, can help prevent future heart problems in people who have coronary artery disease and recently had a stent placed. It's for adults with at least one extra risk factor like diabetes, smoking, or high blood pressure.
This trial tests if giving colchicine early after a heart attack (when a drug-coated stent is placed) can help reduce complications. It looks at short-term benefits for people with Non-STEMI.
This trial is for people who had a heart attack and received a specific type of stent (Orsiro). It tests a combination of a single antiplatelet drug and colchicine to see if it helps prevent future heart problems. Colchicine is a medicine that reduces inflammation and might lower the risk of another heart attack.
This trial tests whether a low dose of the anti-inflammatory drug colchicine can help people who have recently had a heart attack or unstable angina. It aims to see if colchicine reduces the risk of future heart problems.
This trial tests whether colchicine, a drug that reduces inflammation, can help prevent further heart problems or strokes in people with moderate chronic kidney disease. You may be eligible if you have kidney disease and have had a heart attack, stroke, or related event in the past.
Hear when a new Coronary Heart Disease (CHD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.